Stoke Therapeutics Inc (STOK)
13.90
-0.13
(-0.93%)
USD |
NASDAQ |
May 17, 16:00
13.90
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics Shares Outstanding: 52.12M for April 29, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 29, 2024 | 52.12M |
April 08, 2024 | 52.12M |
April 02, 2024 | 51.86M |
March 31, 2024 | 46.50M |
March 15, 2024 | 46.30M |
December 31, 2023 | 45.92M |
October 30, 2023 | 44.65M |
September 30, 2023 | 44.29M |
September 18, 2023 | 44.29M |
September 01, 2023 | 44.29M |
July 31, 2023 | 44.26M |
June 30, 2023 | 44.20M |
April 26, 2023 | 44.19M |
April 17, 2023 | 44.19M |
March 31, 2023 | 44.18M |
February 23, 2023 | 44.15M |
December 31, 2022 | 39.44M |
October 31, 2022 | 39.43M |
September 30, 2022 | 39.43M |
July 31, 2022 | 39.42M |
June 30, 2022 | 39.38M |
May 02, 2022 | 39.19M |
April 11, 2022 | 39.14M |
March 31, 2022 | 39.04M |
March 01, 2022 | 37.36M |
Date | Value |
---|---|
December 31, 2021 | 36.90M |
November 01, 2021 | 36.79M |
September 30, 2021 | 36.78M |
August 03, 2021 | 36.75M |
June 30, 2021 | 36.72M |
May 03, 2021 | 36.71M |
April 12, 2021 | 36.70M |
March 31, 2021 | 36.70M |
March 01, 2021 | 36.66M |
December 31, 2020 | 36.58M |
November 24, 2020 | 36.35M |
November 05, 2020 | 33.47M |
September 30, 2020 | 33.36M |
August 04, 2020 | 33.24M |
July 08, 2020 | 33.22M |
June 30, 2020 | 33.21M |
May 08, 2020 | 32.97M |
April 06, 2020 | 32.96M |
March 31, 2020 | 32.97M |
March 16, 2020 | 32.94M |
December 31, 2019 | 32.86M |
November 12, 2019 | 32.73M |
September 30, 2019 | 32.72M |
August 14, 2019 | 32.72M |
June 30, 2019 | 32.67M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
30.27M
Minimum
Jun 07 2019
52.12M
Maximum
Apr 29 2024
38.62M
Average
36.79M
Median
Nov 01 2021
Shares Outstanding Benchmarks
NeuBase Therapeutics Inc | 3.729M |
iBio Inc | 3.484M |
Actinium Pharmaceuticals Inc | 29.78M |
Lixte Biotechnology Holdings Inc | 2.249M |
Fate Therapeutics Inc | 113.83M |